695467

1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decan

97%

• Synonym(e): 1,3,5-Triaza-7-Phosphaadamantan, NSC 266642, PTA
• Empirische Formel (Hill-System): C₆H₁₂N₃P
• CAS-Nummer: 53597-69-6
• Molekulargewicht: 157.15
• MDL-Nummer: MFCD00154905
• UNSPSC-Code: 12352005
• PubChem Substanz-ID: 329761745
• NACRES: NA.22

Eigenschaften

• Qualitätsniveau: 100
• Assay: 97%
• Form: solid
• Eignung der Reaktion: reagent type: ligand; reaction type: Hydroformylations; reagent type: ligand; reaction type: Hydrogenations; reagent type: ligand; reaction type: Morita-Baylis-Hillman Reactions; reagent type: ligand; reaction type: Sonogashira Coupling; reagent type: ligand; reaction type: Suzuki-Miyaura Coupling
• mp (Schmelzpunkt): 244-250 °C
• Funktionelle Gruppe: phosphine
• SMILES String: C1N2CN3CN1CP(C2)C3
• InChI: 1S/C6H12N3P/c1-7-2-9-3-8(1)5-10(4-7)6-9/h1-6H2
• InChIKey: FXXRPTKTLVHPAR-UHFFFAOYSA-N

Beschreibung

Allgemeine Beschreibung

Air stable organocatalyst for Baylis-Hillman transformation

Anwendung

• The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics.: This study examines the antimetastatic properties of ruthenium compounds using DIGE proteomics. The involvement of 1,3,5-Triaza-7-phosphaadamantane in the complexation with ruthenium and its biological effects were analyzed, highlighting its potential in anticancer therapies (Guidi et al., 2013).
• Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes.: This research details the synthesis of novel silver complexes containing 1,3,5-Triaza-7-phosphaadamantane, evaluating their antimicrobial and antiproliferative activities, which demonstrates the compound′s utility in biomedical applications (Pettinari et al., 2011).

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable